Current role
Roman Bradel, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Roman Bradel, Ph.D.
Supernus Pharmaceuticals, Inc. reported in an 8-K filed February 21, 2024 that Roman Bradel, Ph.D. was appointed Vice President, Regulatory Affairs.
“The Company expects Roman Bradel, Ph.D. to join the Company in March 2024 as its Vice President, Regulatory Affairs reporting to Frank Mottola, the Company's Senior Vice President, Quality, GMP Operations and IT.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-02-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Supernus Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Jack A. Khattar CEO, Board Member
- Jack Khattar CEO, Board Member
- Tony Kingsley Chairman
- James Kelly CFO
- James P. Kelly CFO
- Timonthy C. Dec CFO
- Timothy C. Dec CFO
- Bethany L. Sensenig Board Member
- Carrolee Barlow Board Member
- Charles W. Newhall Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.